David P. Luci - Jul 27, 2022 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: David P. Luci
Stock symbol
ACXP
Transactions as of
Jul 27, 2022
Transactions value $
$75,001
Form type
4
Date filed
7/29/2022, 05:01 PM
Previous filing
Nov 22, 2021
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Purchase $75K +19.7K +1.96% $3.80 1.03M Jul 27, 2022 Direct
holding ACXP Common Stock 15.1K Jul 27, 2022 By spouse
holding ACXP Common Stock 35K Jul 27, 2022 By child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Purchase $0 +19.7K $0.00 19.7K Jul 27, 2022 Common Stock 19.7K $3.55 Direct
transaction ACXP Warrants for Common Stock Purchase $0 +19.7K $0.00 19.7K Jul 27, 2022 Common Stock 19.7K $3.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.